Yiqi Su

444 total citations
24 papers, 269 citations indexed

About

Yiqi Su is a scholar working on Epidemiology, Infectious Diseases and Nephrology. According to data from OpenAlex, Yiqi Su has authored 24 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Nephrology. Recurrent topics in Yiqi Su's work include Cytomegalovirus and herpesvirus research (13 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Acute Kidney Injury Research (5 papers). Yiqi Su is often cited by papers focused on Cytomegalovirus and herpesvirus research (13 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Acute Kidney Injury Research (5 papers). Yiqi Su collaborates with scholars based in United States, China and Greece. Yiqi Su's co-authors include Genovefa A. Papanicolaou, Miguel‐Angel Perales, Sergio Giralt, Anat Stern, Ann A. Jakubowski, Brian C. Shaffer, Susan K. Seo, Phaedon D. Zavras, Roni Tamari and Yeon Joo Lee and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Metabolism.

In The Last Decade

Yiqi Su

21 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiqi Su United States 8 241 140 72 35 22 24 269
A L Bruu Norway 6 84 0.3× 84 0.6× 13 0.2× 18 0.5× 9 0.4× 10 182
Dante P. Melendez United States 7 136 0.6× 61 0.4× 22 0.3× 6 0.2× 15 0.7× 11 194
Joel E. Gallant United States 6 157 0.7× 173 1.2× 14 0.2× 6 0.2× 15 0.7× 8 282
Anna De Bona Italy 8 155 0.6× 87 0.6× 14 0.2× 7 0.2× 22 1.0× 21 223
Natalya Zaidan Maluf Brazil 2 177 0.7× 31 0.2× 51 0.7× 5 0.1× 18 0.8× 4 203
Craig L K Boge United States 8 95 0.4× 64 0.5× 27 0.4× 9 0.3× 5 0.2× 14 140
Paola Corsi Italy 14 106 0.4× 353 2.5× 30 0.4× 6 0.2× 10 0.5× 30 448
Vera Aparecida dos Santos Brazil 6 240 1.0× 42 0.3× 48 0.7× 4 0.1× 21 1.0× 6 273
Lynne M. Shelley United States 5 259 1.1× 140 1.0× 112 1.6× 3 0.1× 11 0.5× 5 293
Alistair Reid Australia 7 226 0.9× 111 0.8× 15 0.2× 12 0.3× 3 0.1× 13 273

Countries citing papers authored by Yiqi Su

Since Specialization
Citations

This map shows the geographic impact of Yiqi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqi Su more than expected).

Fields of papers citing papers by Yiqi Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqi Su. The network helps show where Yiqi Su may publish in the future.

Co-authorship network of co-authors of Yiqi Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yiqi Su. A scholar is included among the top collaborators of Yiqi Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiqi Su. Yiqi Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Leo, Yiqi Su, Jiarui Xu, et al.. (2025). Inhibition of matrix metalloproteinase-9 attenuates kidney fibrosis and cellular senescence in the transition from acute kidney injury to chronic kidney disease. Renal Failure. 47(1). 2499897–2499897. 4 indexed citations
3.
Shen, Ziyan, Zhi Hong Chen, Li Yang, et al.. (2025). Early Efficacy and Safety of Finerenone on Type 2 Diabetes‐Related Chronic Kidney Disease: A Real‐World Observational Study in China. Diabetes/Metabolism Research and Reviews. 41(6). e70078–e70078. 1 indexed citations
5.
Su, Yiqi, Y. Li, Renee L. Gennarelli, et al.. (2024). Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(8). 792.e1–792.e12. 3 indexed citations
7.
Zavras, Phaedon D., Yiqi Su, Jiaqi Fang, et al.. (2022). Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(7). 403.e1–403.e7. 6 indexed citations
10.
Su, Yiqi, Anat Stern, Tamara Nawar, et al.. (2022). Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study. Clinical Infectious Diseases. 75(5). 795–804. 32 indexed citations
11.
Lee, Yeon Joo, Yiqi Su, Christina Cho, et al.. (2021). Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell–Depleted Hematopoietic Cell Transplant. The Journal of Infectious Diseases. 225(3). 453–464. 4 indexed citations
12.
Lee, Yeon Joo, Yiqi Su, Christina Cho, & Genovefa A. Papanicolaou. (2021). Donor-CD4+ T Cells: A Trojan Horse for Human Herpes Virus-6 After Allogeneic Hematopoietic Cell Transplantation?. The Journal of Infectious Diseases. 225(3). 552–553. 2 indexed citations
13.
Stern, Anat, Yiqi Su, Henry Dumke, et al.. (2021). Cytomegalovirus Viral Load Kinetics Predict Cytomegalovirus End-Organ Disease and Mortality After Hematopoietic Cell Transplant. The Journal of Infectious Diseases. 224(4). 620–631. 13 indexed citations
14.
Su, Yiqi, et al.. (2021). Management of acute kidney injury in gastrointestinal tumor: An overview. World Journal of Clinical Cases. 9(35). 10746–10764. 2 indexed citations
15.
Stern, Anat, Yiqi Su, Yeon Joo Lee, et al.. (2020). A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(6). 1195–1202. 36 indexed citations
16.
Fang, Jiaqi, Yiqi Su, Phaedon D. Zavras, et al.. (2020). Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(10). 1937–1947. 17 indexed citations
17.
Zavras, Phaedon D., Yiqi Su, Jiaqi Fang, et al.. (2020). Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study. Biology of Blood and Marrow Transplantation. 26(8). 1482–1491. 38 indexed citations
18.
Lin, Andrew, Molly Maloy, Yiqi Su, et al.. (2019). Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience. Transplant Infectious Disease. 21(6). e13187–e13187. 65 indexed citations
19.
Huang, Yao-Ting, Yiqi Su, Seong-Jin Kim, et al.. (2018). Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes. Biology of Blood and Marrow Transplantation. 25(4). 791–799. 10 indexed citations
20.
Su, Yiqi. (2015). 330 Bidirectional Relationship Between Diabetes and Acute Pancreatitis: A Population-Based Cohort Study in Taiwan. Annals of Emergency Medicine. 66(4). S119–S120. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026